Literature DB >> 15769910

Antibiotic treatment of Lyme borreliosis: what is the evidence?

R Dinser1, M C Jendro, S Schnarr, H Zeidler.   

Abstract

Antibiotic treatment of all disease manifestations after infection with Borrelia sensu lato spp aims at resolving the presenting disease manifestation and preventing late stage disease. The goals are resolution of the preventing manifestation and prevention of the spread of bacteria to prevent late disease like arthritis. Different borrelial species prevail in Europe. The natural disease course of European borreliosis is not well defined and the effect of antibiotic treatment is unclear.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15769910      PMCID： PMC1755466          DOI： 10.1136/ard.2004.027367

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  54 in total

1.  Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis.

Authors:  D Carlson; J Hernandez; B J Bloom; J Coburn; J M Aversa; A C Steere
Journal:  Arthritis Rheum       Date:  1999-12

2.  Long-term results in patients with Lyme arthritis following treatment with ceftriaxone.

Authors:  H Valesová; J Mailer; J Havlík; D Hulínská; J Hercogová
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

3.  Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals?

Authors:  H Fahrer; M J Sauvain; E Zhioua; C Van Hoecke; L E Gern
Journal:  Eur J Epidemiol       Date:  1998-02       Impact factor: 8.082

4.  Comparison of azithromycin and doxycycline in the treatment of erythema migrans.

Authors:  B Barsic; T Maretic; L Majerus; J Strugar
Journal:  Infection       Date:  2000 May-Jun       Impact factor: 3.553

5.  Incidence of Lyme borreliosis in the Würzburg region of Germany.

Authors:  H I Huppertz; M Böhme; S M Standaert; H Karch; S A Plotkin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-10       Impact factor: 3.267

6.  Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy.

Authors:  W Bentas; H Karch; H I Huppertz
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

7.  Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis.

Authors:  B Jaulhac; R Heller; F X Limbach; Y Hansmann; D Lipsker; H Monteil; J Sibilia; Y Piémont
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

8.  Long-term outcomes of persons with Lyme disease.

Authors:  E G Seltzer; M A Gerber; M L Cartter; K Freudigman; E D Shapiro
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

9.  The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study.

Authors:  M C Reid; R T Schoen; J Evans; J C Rosenberg; R I Horwitz
Journal:  Ann Intern Med       Date:  1998-03-01       Impact factor: 25.391

10.  Azithromycin versus penicillin V for the treatment of early Lyme borreliosis.

Authors:  K Weber; B Wilske; V Preac-Mursic; R Thurmayr
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553
View more
  3 in total

Review 1.  [Polyneuropathy in the elderly].

Authors:  Wolfgang Löscher; Bernhard Iglseder
Journal:  Z Gerontol Geriatr       Date:  2017-04-28       Impact factor: 1.281

2.  Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study.

Authors:  J Oksi; J Nikoskelainen; H Hiekkanen; A Lauhio; M Peltomaa; A Pitkäranta; D Nyman; H Granlund; S-A Carlsson; I Seppälä; V Valtonen; M Viljanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

Review 3.  Treatment of Lyme borreliosis.

Authors:  Hermann J Girschick; Henner Morbach; Dennis Tappe
Journal:  Arthritis Res Ther       Date:  2009-12-17       Impact factor: 5.156
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.